Christian LaPointe net worth and biography

Christian LaPointe Biography and Net Worth

General Counsel of Quantum-Si

Christian LaPointe, Ph.D. has served as Quantum-Si’s General Counsel since November 2020. Prior to joining Quantum-Si, Dr. LaPointe served as General Counsel at ArcherDX, Inc., a genomics company, from January 2015 to August 2019, and as Deputy General Counsel at ArcherDX from August 2019 to October 2020. Dr. LaPointe also served as General Counsel to Celsee, Inc., a single cell analysis solutions provider, from August 2019 to June 2020. Previously, Dr. LaPointe was General Counsel at Thrive Bioscience, Inc., a cell culture instruments and software company, from August 2014 to July 2019, General Counsel of the Enzymatics enzyme solutions unit of QIAGEN N.V., from March 2013 to January 2015, General Counsel of Axios Biosciences, LLC, an oncology drug discovery company, from December 2012 to December 2014, and a litigation attorney at the law firm Sherin and Lodgen LLP from April 2012 to March 2013. Dr. LaPointe received his B.S. in biochemistry from the University of New Hampshire, his Ph.D. in biochemistry from Dartmouth College and his J.D. from Suffolk University Law School.

What is Christian LaPointe's net worth?: The estimated net worth of Christian LaPointe is at least $726,071.70 as of August 9th, 2024. Dr. LaPointe owns 571,710 shares of Quantum-Si stock worth more than $726,072 as of March 30th. This net worth estimate does not reflect any other assets that Dr. LaPointe may own. Learn More about Christian LaPointe's net worth.
How do I contact Christian LaPointe?: The corporate mailing address for Dr. LaPointe and other Quantum-Si executives is 452 FIFTH AVENUE 21ST FLOOR, NEW YORK NY, 10018. Quantum-Si can also be reached via phone at 866-688-7374 and via email at ir@quantum-si.com. Learn More on Christian LaPointe's contact information.
Has Christian LaPointe been buying or selling shares of Quantum-Si?: Christian LaPointe has not been actively trading shares of Quantum-Si during the last quarter. Most recently, on Friday, August 9th, Christian Lapointe bought 25,000 shares of Quantum-Si stock. The stock was acquired at an average cost of $0.86 per share, with a total value of $21,500.00. Following the completion of the transaction, the general counsel now directly owns 571,710 shares of the company's stock, valued at $491,670.60. Learn More on Christian LaPointe's trading history.
Who are Quantum-Si's active insiders?: Quantum-Si's insider roster includes Christian LaPointe (General Counsel), and John Stark, VIII (CEO). Learn More on Quantum-Si's active insiders.
Are insiders buying or selling shares of Quantum-Si?: In the last year, Quantum-Si insiders bought shares 4 times. They purchased a total of 245,000 shares worth more than $213,522.00. In the last year, insiders at the sold shares 8 times. They sold a total of 3,556,943 shares worth more than $11,778,589.61. The most recent insider tranaction occured on March, 21st when CEO Jeffrey Alan Hawkins sold 23,707 shares worth more than $32,952.73. Insiders at Quantum-Si own 30.0% of the company. Learn More about insider trades at Quantum-Si.
Information on this page was last updated on 3/21/2025.

Christian LaPointe Insider Trading History at Quantum-Si

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/9/2024	Buy	25,000	$0.86	$21,500.00	571,710
3/15/2024	Buy	10,000	$1.74	$17,400.00	257,693
3/15/2023	Buy	20,000	$1.77	$35,400.00	247,693
8/17/2022	Buy	20,000	$3.93	$78,600.00	227,693
1/10/2022	Sell	12,111	$5.86	$70,970.46

Christian LaPointe Buying and Selling Activity at Quantum-Si

Quantum-Si Company Overview

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.

Today's Range

Now: $1.27

$1.25

$1.33

50 Day Range

MA: $1.71

$1.14

$2.44

2 Week Range

Now: $1.27

$0.61

$5.77

Volume

3,162,139 shs

Average Volume

9,544,839 shs

Market Capitalization

$232.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.75